These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7180486)

  • 1. [Evaluation of the new formulations of aspirin tablets in bioavailability].
    Bao JX; Fu YK; Xu AX; Li SN; Wu YM
    Yao Xue Xue Bao; 1982 Jul; 17(7):540-5. PubMed ID: 7180486
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the bioavailability of aspirin tablets and suppositories.
    Superstine SY; Superstine E; Penchas S
    Isr J Med Sci; 1978 Feb; 14(2):292-4. PubMed ID: 649361
    [No Abstract]   [Full Text] [Related]  

  • 3. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bioavailability of buffered acetylsalicylic acid].
    Finzi GF; Riolo U; Ghini R
    Arch Sci Med (Torino); 1981; 138(4):467-9. PubMed ID: 7340731
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
    Paton TW; Walker SE; Leung FY; Little AH
    Clin Pharm; 1983; 2(2):165-6. PubMed ID: 6883946
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preclinical and clinical pharmacokinetic study of orally administered effervescent acetylsalicylic acid tablets].
    Dévay A; Uderszky J; Tanay J; Nyitrai T; Sátori E; Rácz I
    Acta Pharm Hung; 1985 May; 55(3):114-8. PubMed ID: 4036626
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioavailability studies on a buffered acetylsalicylic acid preparation.
    Ekenved G; Elofsson R; Sölvell L
    Acta Pharm Suec; 1975; 12(4):323-32. PubMed ID: 1106118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the influence of uptake conditions on the bioavailability of different acid acetyl salicylic formulations (author's transl)].
    Trublin F; Robert H; Delcambre B
    J Pharm Belg; 1980; 62(6):427-36. PubMed ID: 7463303
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo-in vitro correlations with various aspirin formulations.
    Alcorn GJ; Lücker PW; Procaccini RL; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):761-7. PubMed ID: 3448453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and tolerance studies on acetylsalicylic acid suppositories.
    Borg KO; Ekenved G; Elofsson R; Sjögren J; Sölvell L
    Acta Pharm Suec; 1975; 12(5-6):491-8. PubMed ID: 1217502
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative bioavailability of sustained-release and uncoated aspirin tablets.
    Karahalios WJ; Sawyer WT; Rittase RA; Maynard SA
    Am J Hosp Pharm; 1981 Nov; 38(11):1754-6. PubMed ID: 7304632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic comparison of three aspirin preparations and placebo.
    Petroski D
    Clin Ther; 1993; 15(2):314-20. PubMed ID: 8519040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The transmural gastric potential difference in combination with pharmacokinetic profiles. A new approach to combine kinetic and dynamic properties of compounds.
    Vance J; Lücker PW; Tilling W; Procaccini R; Wetzelsberger N
    Methods Find Exp Clin Pharmacol; 1982; 4(7):533-8. PubMed ID: 7169839
    [No Abstract]   [Full Text] [Related]  

  • 14. Dipyridamole bioavailability in subjects with reduced gastric acidity.
    Derendorf H; VanderMaelen CP; Brickl RS; MacGregor TR; Eisert W
    J Clin Pharmacol; 2005 Jul; 45(7):845-50. PubMed ID: 15951475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of aspirin-magaldrate double-layer tablets: in vitro evaluation and cytoprotective activity in rats.
    al Gohary OM; el Din K; el Tahir H
    Boll Chim Farm; 1996; 135(7):421-8. PubMed ID: 9035555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the tape and concentration of carboxymethylstarch on the bioavailability of aspirin in tablets].
    Tape LG; Robert H; Guyot-Hermann AM
    Farmaco Prat; 1982 Apr; 37(4):128-38. PubMed ID: 7084442
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biopharmaceutics of drugs. Application to three tablet formulations of acetylsalicylic acid].
    Cid E; Moran I
    J Pharm Belg; 1975; 30(3):279-91. PubMed ID: 1206460
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of sustained-release aspirin preparations.
    Lobeck F; Spigiel RW
    Clin Pharm; 1986 Mar; 5(3):236-8. PubMed ID: 3956130
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative gastric irritation by two buffered acetylsalicylic acid formulations and acetylsalicylic acid. A gastric potential difference analysis.
    Bruhn R; Ganote DP; Lücker PW; Vance J; Procaccini RL
    Arzneimittelforschung; 1983; 33(1):158-60. PubMed ID: 6681968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.